Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00799981
Other study ID # YA-LOF-0015
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2008
Est. completion date March 2009

Study information

Verified date April 2021
Source Wellspect HealthCare
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A study comparing a 10 cm catheter with a 7 cm catheter in a group of female patients who, on a routine bases, empty their bladder using urinary catheters, by measuring residual urine after intermittent catheterization.


Description:

The study personnel will conduct three bladder scans after each catheterization in order to obtain the mean residual urine volume. Each patient will catheterize herself two times with each product, i.e. a total of four catheterizations. Diagnosis and BMI will be collected at visit 1 to assess whether the residual urine volume differs between these subgroups. The hypothesis that the mean residual volumes were equal when using the 7 and the 10 centimeter catheters was tested by means of the Wilcoxon signed rank test.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date March 2009
Est. primary completion date January 2009
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Provision of signed informed consent - Female subjects aged 18 years and over - Experienced users of CIC with a minimum of one month of use - Practice CIC a minimum of 1 time per day - Practice CIC with female catheters with a maximum length of 20 cm - Perform self-catheterization - Sufficient hand function to be able to open and handle catheter packages - Use catheters with Ch 10, 12 or 14 Exclusion Criteria: - Pregnancy - Ongoing symptomatic UTI - Involvement in the planning and conduct of the study (applies to both Astra Tech staff or staff at the study site) - Previous enrolment or randomisation of treatment in the present study - Participation in another clinical study during the study period - Severe non-compliance to protocol as judged by the investigator and/or Astra Tech

Study Design


Related Conditions & MeSH terms


Intervention

Device:
A=SpeediCath Compact 7 cm and B=POBE 10 cm
Catheterization should resemble the daily use as far as possible and at least 2 hours had to pass between 2 catheterizations.The study centre decided whether the subject performed all four catheterizations on one or several days.

Locations

Country Name City State
Sweden Rehabiliteringskliniken, Södra Älvsborgs Sjukhus Borås
Sweden Verksamhet Urologi, Sahlgrenska Universitetssjukhuset Gothenburg
Sweden Clinical Research and Trial Centre, Lund University Hospital Lund

Sponsors (1)

Lead Sponsor Collaborator
Wellspect HealthCare

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Bladder Scan Measurements of Residual Urine Volume Measurements were performed with the bladder scan BVI 3000. The primary outcome variable was average residual urine volume (mL) calculated from repetitive bladder scans performed after each catheterization.
Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated.
Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.
Secondary Number of Subjects With a Residual Volume >5mL or =5mL Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. At least 2 hours had to pass between 2 catheterizations.
Secondary Number of Subjects With a Residual Volume >10mL or =10mL Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.
Secondary Number of Subjects With a Residual Volume >30mL or =30mL Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.
Secondary Number of Subjects With a Residual Volume >50mL or =50mL Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.
Secondary Does the Subject's Bladder Feel Completely Empty After Catheterisation (All Subjects) After each catheterization the study nurse will ask the subject whether it feels as if the bladder is completely emptied or not.
0=No and 1=Yes.
Question asked minutes after catheterization.
See also
  Status Clinical Trial Phase
Completed NCT00389558 - Antiseptic Use and Dressing Application Phase 4
Completed NCT01479153 - Venous Site for Central Catheterization N/A
Recruiting NCT01142934 - Trial on the Efficacy of Tegaderm Chlorhexidine Gluconate (CHG) in Reducing Catheter Related Bloodstream Infections Phase 4
Completed NCT00516906 - Clinical Performance of a Chlorhexidine Antimicrobial Dressing Phase 2/Phase 3
Not yet recruiting NCT03303274 - A Difference in Subclavian Vein Catheterization Between Supine and Lateral Tilt Position - Stage II N/A
Not yet recruiting NCT03296735 - A Difference in Subclavian Vein Catheterization Between Supine and Lateral Tilt Position - Stage I N/A
Completed NCT04714255 - Efficacy of Art Intervention on Decreasing Pain and Anxiety During Intravenous Cannulation N/A
Completed NCT03677765 - Comparisons of Complications Related to Two Approaches of Ultrasonography-guided Subclavian Venous Catheterization N/A
Recruiting NCT02299752 - Unnoticed Gloves Perforation N/A
Completed NCT00802750 - Study Where Healthy Volunteers Evaluate LoFric Catheters N/A
Completed NCT03582540 - Early Versus Delayed Double-guidewire Technique in Difficult Biliary Cannulation. (DFG) N/A
Completed NCT02899546 - Study of Peripherally Inserted Central Catheter (PICC)-Related Infections in a Tropical Area
Completed NCT04865783 - Cryospray to Reduce Pain During Venous Cannulation N/A
Completed NCT02431858 - Catheter Over Needle vs Catheter Through Needle Phase 4
Completed NCT01133652 - Variation In Success of Intravenous (IV) Placement With Observation Using New Techniques Phase 4
Completed NCT05317533 - Prevalence of Distal Radial Artery Occlusion in Cardiovascular Catheterization Via Distal Radial Access
Completed NCT01347463 - Validation of the Ipsilateral Nipple as the Directional Guide for Internal Jugular Vein (IJV) Catheterization
Terminated NCT00482547 - Study of a Urethral Catheter Coated With Eluting Silver Salts (SUCCESS) Phase 4
Completed NCT00226226 - Peripherally Inserted Central Catheter Placement by IV Team Nurses Using the Sonic Flashlight Phase 1
Completed NCT03565419 - Use of Smart Glasses for Ultrasound Guided Peripheral Venous Access N/A